Evidence map›Paper›PMID 34745885›Full record

ArticleIDCases2021

Utilization of whole genome sequencing for resolution of discrepant

Susan Realegeno, Oladunni Adeyiga, Drew J Winston, Omer E Beaird, Omai B Garner, Shangxin Yang

Abstract readCase Reports
In one paragraph

Article in IDCases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Susan RealegenoUCLA Clinical Microbiology Laboratory, Department of Pathology & Laboratory Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
Oladunni AdeyigaDivision of Infectious Diseases, Department of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
Drew J WinstonDivision of Hematology and Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
Omer E BeairdDivision of Infectious Diseases, Department of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
Omai B GarnerUCLA Clinical Microbiology Laboratory, Department of Pathology & Laboratory Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
Shangxin YangUCLA Clinical Microbiology Laboratory, Department of Pathology & Laboratory Medicine, University of California, Los Angeles, Los Angeles, CA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 44-year-old woman undergoing therapy for acute promyelocytic leukemia (APL) developed disseminated tuberculosis.

Indexed as

Drug resistance predictionDSTMycobacterium tuberculosisWhole genome sequencing

Identifiers

PMID34745885
PMCPMC8551521

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.